drugset / Trial / NCT04454307

Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients

NCT04454307

Phase 1/2 Unknown 100 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

The rationale of the use of tramadol for COVID-19 patients is attributed to its anti-inflammatory, hypocagulatory, antioxidant, cardio-protective, analgesic, antitussive, bactericidal and antidepressant effect.

Timeline

Start
2020-07
Primary completion
2020-08
Completion
2020-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 100 mg

Indications